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Abstract
Dental pulp stem cells (DPSCs) have emerged as a promising tool with great 
potential for use in tissue regeneration and engineering. Some of the main 
advantages of these cells are their multifaceted differentiation capacity, along with 
their high proliferation rate, a relative simplicity of extraction and culture that 
enables obtaining patient-specific cell lines for their use in autologous cell 
therapy. PubMed, Scopus and Google Scholar databases were searched for 
relevant articles related to the use of DPSCs in regeneration of dentin-pulp 
complex (DPC), periodontal tissues, salivary gland and craniomaxillofacial bone 
defects. Few studies were found regarding the use of DPSCs for regeneration of 
DPC. Scaffold-based combined with DPSCs isolated from healthy pulps was the 
strategy used for DPC regeneration. Studies involved subcutaneous implantation 
of scaffolds loaded with DPSCs pretreated with odontogenic media, or performed 
on human tooth root model as a root slice. Most of the studies were related to 
periodontal tissue regeneration which mainly utilized DPSCs/secretome. For 
periodontal tissues, DPSCs or their secretome were isolated from healthy or 
inflamed pulps and they were used either for preclinical or clinical studies. 
Regarding salivary gland regeneration, the submandibular gland was the only 
model used for the preclinical studies and DPSCs or their secretome were isolated 
only from healthy pulps and they were used in preclinical studies. Likewise, 
DPSCs have been studied for craniomaxillofacial bone defects in the form of 
mandibular, calvarial and craniofacial bone defects where DPSCs were isolated 
only from healthy pulps for preclinical and clinical studies. From the previous 
results, we can conclude that DPSCs is promising candidate for dental and oral 
tissue regeneration.
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Core Tip: Dental pulp stem cells (DPSCs) can be isolated from the pulps of impacted 
teeth requiring surgical extraction or from teeth extracted for orthodontic reasons. In 
addition, there is growing evidence that DPSCs can be isolated from inflamed pulps 
derived from carious teeth with symptomatic irreversible pulpitis. DPSCs are neural 
crest in origin, and thus they differentiate into an astonishing array of cell types and 
tissues and regenerate structures that have the same developmental origin, like dentin-
pulp complex, periodontal tissues, stromal tissues of salivary glands and craniomaxillo-
facial bone defects.
Citation: Grawish ME, Saeed MA, Sultan N, Scheven BA. Therapeutic applications of dental 
pulp stem cells in regenerating dental, periodontal and oral-related structures. World J Meta-




The oral cavity is a complex multi-organic structure, where oral tissues and organs are 
linked developmentally and functionally. Irreversible damage to any of them is more 
likely to affect the others, causing extensive malfunction. Tooth decay, periodontal 
diseases, alveolar bone resorption, and impaired salivary gland (SG) function are 
conditions that seriously affect oral health. Synthetic materials have traditionally been 
used as the treatment of choice in prosthetic and restorative dentistry. However, this 
form of replacement does not regenerate the original biological tissues and other 
organs, such as SGs, are simply not responsive to mechanical substitution approaches. 
Thus, tissue engineering (TE) is emerging as a new therapeutic choice for the complete 
biological regeneration of craniomaxillofacial tissues and organs. Three critical 
components are required: (1) stem cells; (2) scaffolds; and (3) stimulating factors or 
inductive signals[1].
Dental pulp stem cells (DPSCs) are neural crest-derived cells with an excellent 
ability to differentiate along multiple cell lineages (Figure 1). In particular, simple in 
vitro protocols can be used to achieve highly efficient osteo/dentinogenic 
differentiation of DPSCs, making these cells a very attractive and promising tool for 
the future treatment of dental and periodontal diseases. Among oral-related 
structures, regeneration of the SGs and bone defects appears to be possible using 
DPSCs, as researchers over the last decade have made substantial progress in 
experimental models of partial or total regeneration of both organs[2]. Emerging 
approaches using cell-free therapy with cell extracts or secretome components also 
exhibit favorable outcomes and when compared to cell-based approaches, the 
secretome can be relatively easily obtained, quantified and are more stable for long-
term storage to be used in various TE fields[3].
In this review, we explored the potential usage of DPSCs in preclinical and clinical 
trials for the regeneration of different oral, dental and craniomaxillofacial tissues and 
organs. Therefore, PubMed, Scopus and Google Scholar databases were searched for 
relevant articles related to the use of DPSCs in regeneration of dentin-pulp complex 
(DPC), periodontal tissues, SG and craniomaxillofacial bone defects. We present the 
different strategies used in experimental regenerative models with potential 
applications in dentistry and oral medicine. Based on data extraction from the different 
databases, we can conclude that DPSCs may be an ideal choice to be used in 
experimental models of tissue-engineered reconstruction of organs of the oral cavity, 
and the paradigmatic cases of the tooth and the SG may constitute the leading edge of 
a massive research effort on next generation organ replacement therapies.
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Figure 1 Different types of regeneration possible from dental pulp stem cells. Schematic diagram showing multi-differentiation capability of dental 
pulp stem cells (DPSCs) for regenerating dentin-pulp complex, periodontal tissues, stromal tissues of salivary glands and craniomaxillofacial bone defects.
REGENERATION OF DPC USING DPSCS
Teeth are composed of various dental tissues, viz. enamel, dentin, pulp, and 
cementum. Dentin and pulp formulate the DPC that preserves tooth viability and 
integrity[4]. On one hand, the pulp provides dentin with moisture, nutriment, and 
minerals to keep its resiliency and degree of mineralization; therefore, in the case of 
pulp necrosis, dentin gets dark and brittle with the sequelae of tooth discoloration and 
fracture. On the other hand, dentin provides a closed protecting barrier for the pulp 
against bacterial toxins and physical or chemical irritants; therefore, dentin damage or 
pulp exposure seriously threaten tooth vitality and integrity[5].
Following carious or traumatic injury to dentine-pulp, a complex interplay between 
host defense response, inflammatory and infective agents and endogenous repair 
processes occur. DPC is a difficult structure to manufacture in vitro or repair in vivo or 
ex vivo. Embryologically, dentinogenesis starts with the secretion and cross basement 
membrane transport of signaling proteins from the differentiating ameloblasts during 
the early bell stage of tooth development. Amongst many cytokines and growth 
factors, the TGFβ is considered to initiate the dentinogenesis process through inducing 
odontogenic differentiation of the undifferentiated ectomesenchymal cells of the 
dental papilla[6]. During development and after enamel maturation and tooth 
eruption, ameloblasts are lost forever; therefore, recreating the dentinogenesis process 
again in TE without ameloblasts is difficult due to the absence of the initiator. 
Histologically, the DPC is formed of two different tissues. The outermost layer of the 
dental pulp (DP) consists of odontoblasts that responsible for the formation of 
primary, secondary and tertiary dentin throughout life. The odontoblastic processes 
may extend from the odontoblasts through the whole thickness of dentin and may be 
embedded in the enamel as enamel spindles, dentin includes various noncollagenous 
proteins that control the activity of odontoblasts, fibroblasts and DPSCs[7].
Several biomaterials are used to repair the dentin and regenerate DPC, such as 
calcium hydroxide, adhesive resin cement, mineral trioxide aggregate, Biodentine, and 
emdogain. Actually, all these materials are developed on empirical bases, rather than 
on the deep understanding of the histological structure of the DPC or the molecular 
bases of the pulp self-healing mechanism[8]. Consequently, the results of these 
previous studies showed the inability of these materials to regenerate the DPC, and 
only disorganized tissues were formed as a response[9].
The idea of regenerating dentin and pulp tissues is based on recruiting DPSCs via 
several growth factors and scaffolds, what is known as the biological triad of tissue 
regeneration. The DPSCs have a crucial role in the dentinogenesis process as they are 
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responsible for the reconstruction of the damaged dentin and pulp. These cells work 
under the influence of chemical/physical signaling mechanisms that induce stem cell 
differentiation to express the desired phenotype[10]. DPSCs were successfully tested in 
preclinical and clinical studies for DPC regeneration.
Preclinical studies
DPSCs[11-14] and DP progenitor cells[12] have been isolated from permanent teeth 
pulps. In some instances, the cells were transfected with lentivirus virus-mediated 
gene transfer of platelet-derived growth factor (PDGF)[15]. The strategy of using 
DPSCs was dependent on scaffold-based and scaffold-free therapies. DPSCs were 
loaded into the scaffold[12,13] or, incorporated into the scaffold and the combination 
was injected locally[11,14,15]. Nude mice and minipigs were the most selected model 
for studying the regenerative effect of DPSCs for DPC regeneration in the pre-clinical 
trials. The cell number most commonly implicated was 1 × 106[11-13] and an 8 × 106
[14] cell number was also used (Table 1).
DPSCs-derived from healthy pulp: Loading or injecting a cell suspension of DPSCs. 
Horibe et al[13] investigated the regenerative capacity of young and aged human 
(h)DPSCs on ectopic pulp regeneration. They injected 1 × 106 cells combined with 
pepsin-solubilized collagen solution derived from porcine skin into the human tooth 
root model prior to subcutaneous transplantation into 5-wk-old severe combined 
immunodeficiency mice. Evaluation was dependent on histologic and histomorpho-
metric analysis, 28 d after transplantation. They concluded that both young and old 
hDPSCs are promising for clinical applications in DP regeneration.
Wang et al[11] seeded 1 × 106 hDPSCs on nanofibrous poly(L-lactic acid) (PLLA) 
scaffolds, 5.2 mm in diameter and 1.5 mm in thickness. The cell-scaffold constructs 
were induced in odontogenic media for 2 wk prior to subcutaneous implantation in 
nude mice with an age 6-8 wk. A cell-scaffold construct cultured in media without 
odontogenic inducers was used as the control group. The endpoint for this experiment 
was 8 wk after implantation. The histological examinations of the specimens 
illustrated formation of new blood vessels and collagen. The immunohistological 
examin-ation showed high expression of dentin sialoprotein that indicating 
odontogenic differentiation of hDPSCs.
Pan et al[12] investigated the potential of the DP progenitors to regenerate DPC and, 
besides, they clarified the efficacy of stem cell factor (SCF) on DP progenitors for 
odontogenic differentiation and regenerative capability. They mixed 1 × 106 DP 
progenitors with 3 mm × 3 mm × 3 mm collagen sponge sheets that were coated with 
50 ng/mL SCF aqueous solution for a preclinical study. The other groups used in this 
study were collagen sponges with DP progenitors, collagen sponges with SCF, and 
collagen sponges only as a control. The cell-scaffold constructs were implanted into the 
back of male nude mice for 4 wk. After the endpoint of the experiment, the collagen 
sponges were dissected and prepared for histological examination. The results of this 
study revealed a high potentiality of the DP progenitors in DPC regeneration. In 
addition, using the SCF increased the regenerative capacity of DP progenitors.
Chaudhary et al[14] synthesized nanofibrous sponge microspheres (NF-SMS), which 
were used to carry hDPSCs into the pulp cavity to regenerate living DP tissues. They 
removed the DP from 16 molars collected from 2-wk-old rabbits. After that, they 
injected 8 × 106 hDPSCs/NF-SMS complexes pre-cultured under hypoxic condition 
into the rabbit molar pulp cavities prior to subcutaneous implantation into nude mice 
with age of 6-8 wk, for 4 wk. The results of this study were evaluated histologically 
and immunohistochemically. The authors concluded that the hypoxia group 
significantly enhanced angiogenesis inside the pulp chamber and promoted the 
formation of odontoblast-like cells lining the dentin-pulp interface, as compared to the 
control groups, hDPSCs group, NF-SMS group, and hDPSCs/NF-SMS group pre-
cultured under normoxic conditions.
Zhang et al[15] explored the influence of the PDGF-BB on hDPSCs proliferation and 
odontogenic differentiation. They established a PDGF-BB gene-modified hDPSCs 
using lentivirus delivery vector. The genetically-modified hDPSCs were mixed with a 
porous calcium phosphate cement scaffold and implanted subcutaneously in nude 
mice for 12 wk. DPC regeneration was evaluated using histological and immunohis-
tochemical analysis. The conclusion of this study was that the PDGF-BB gene-modified 
hDPSCs can continuously secrete the PDGF-BB protein enhancing dentin-like tissue 
formation. The formed dentin-like mineralized tissue showed positive staining for the 
dentin sialophosphoprotein, similar to tooth dentin tissue, and was surrounded by 
highly vascularized DP-like connective tissue.
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Table 1 Preclinical studies obtained from the PubMed, Scopus and Google Scholar databases related to dentin-pulp complex 
regeneration using dental pulp stem cells
Ref. Strategy Model Defect/site of cell implantation
Cell 
number Cell source Cell application




Nude mice Subcutaneous implantation 1 × 106 hDPSCs Loaded on the top surface of the 
scaffold
Pan et al[12], 2013 Scaffold-
based
Nude mice Subcutaneous implantation 1 × 106 DP 
progenitors
Mixed with collagen sponge sheets and 
SCF












first molar root canal
8 × 106 hDPSCs Loaded into rabbit molar pulp cavity/ 
cell injection into root canals




Nude mice Subcutaneous implantation Not 
detected
hDPSCs Mixed with porous calcium phosphate 
cement
hDPSCs: Human dental pulp stem cells; SCF: Stem cell factor; SCID: Severe combined immunodeficiency.
In another experiment, Chaudhary et al[14] used the maxillary first molars of the 
nude rats as an in situ pulp regeneration model. The entire pulp was removed and the 
root canals were cleaned and shaped using manual #15-#25 K files. After irrigation 
with phosphate-buffered saline and 2.25% NaClO and drying the root canals with 
absorbent points, 8 × 106 hDPSCs/NF-SMS complexes primed under hypoxic 
conditions were injected into the prepared root canals, while those primed under 
normoxic conditions were injected into prepared contralateral first molar root canals. 
After 4 wk, the treated maxillary molars were harvested. For comparison, maxillary 
first molars received no treatment after pulp removal. The histological and 
immunohistochemical analyses of the specimens revealed that the hypoxia-primed 
hDPSCs/NF-SMS could fully fill the molar canals through injection and promoted 
pulp-like tissue formation with intimate integration with the native dentin.
REGENERATION OF PERIODONTAL TISSUES USING DPSCS
The periodontal tissues include two hard and two soft tissues. The two soft tissues are 
periodontal ligament and gingiva, while the two hard ones are alveolar bone lining the 
socket and cementum. The principal function of these structures is investing and 
supporting the teeth to perform their physiologic function. The most common cause 
for tooth loss in adults is the periodontitis, affecting 10%-15% of adults worldwide as 
an advanced type. Treatment modalities such as bone grafts[16], enamel matrix 
derivative[17], platelet-rich plasma (PRP)[18], and guided tissue regeneration[19] 
allow partial improvements in the architecture and function of the periodontal tissues 
but fail to completely regenerate this complex structure. Procedures attempting to 
regenerate the periodontal apparatus have become unconventional and more 
advanced to include dental tissue-derived stem cell therapy[20]. Chiefly, there are two 
approaches for periodontal tissues regeneration, cell-based and cell-free therapies. The 
major concern for the cell-based therapy is the complicated implantation process and it 
includes stem cell injection of cell suspension and stem cell sheet transplantation 
techniques. Engineering of a cell sheet has been adopted through utilizing cell culture 
dishes of temperature-responsive surfaces[21], or by culturing the cells in ascorbic 
acid[22]. Even though cultured cells can be used to study the pathogenesis of the 
inflammatory and immune pathways of periodontal diseases, the complicated host 
defense system basically responsible for these diseases is not amenable to being 
reproduced in vitro. Experimental periodontitis is a preclinical in vivo model for 
studying the possible application of cell therapies and biomaterials-targeted for 
periodontal tissues regeneration. They were considered to be more appropriate 
mimicking the natural host immune response under microbial loads, which can cause 
oral pathological environments and periodontal diseases[23]. Animals like nonhuman 
primates, rodents, rabbits, pigs, and dogs have been selected for modeling human 
periodontitis. Commonly, periodontitis has been induced by placing a silk ligature 
inside gingival sulcus around the molar teeth to serve as a retentive factor for plaque 
and microbial proliferation. In addition, alveolar bone loss has been induced by 
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injection or inoculation of human oral bacteria[24]. DPSCs were successfully tested in 
preclinical and clinical studies for periodontal tissues regeneration.
Preclinical studies
Xenogeneic and autologous[25-32] DPSCs or their exosomes (Exo)[32] have been 
isolated from healthy[25-28,30-32] or inflamed pulps[29]. In some instances, the cells 
were transfected with adenovirus-mediated gene transfer of hepatocyte growth factor 
(HGF)[27]. The strategy of using DPSCs was dependent on scaffold-based 
[25,29,30,32], sandwich structure[31], scaffold-free[26-28] and cell-free[32] therapies. 
Application of DPSCs was in the form of cell injection[26-28,30], cell sheet 
transplantation[27,28,31], loaded onto the scaffold[25,29] or, incorporated onto the 
scaffold and the combination was injected locally[32]. Miniature pigs were the most 
selected model for studying the regenerative effect of DPSCs for periodontal tissues 
regeneration in the pre-clinical trials[26-29]. Other animals such as rats[30], mice[31,32] 
and dogs[25] were also selected for the same purpose. Bone defects of 5 mm width, 7 
mm length and 3 mm depth[26,27] and of 5 mm × 6 mm × 5 mm[28] were the most 
common surgical periodontal defect models created as a site of cell implantation 
(Figure 2). Ligature-induced periodontitis with three-walled periodontal defects 
(PDs)[25], PDs adjacent to the root of the second molars[29], periodontitis created 
using 5-0 silk ligature[32] were also applied as models. Bioroot regeneration was 
accomplished through subcutaneous transplantation of a sandwich structure 
constituted by hDPSCs sheet, human treated dentin matrix (hTDM)/hDPSCs and 
Matrigel/hDPSCs[31]. The cell number of 1 × 107 was the most commonly 
implicated[26-29], and 5 × 105[31], 2 × 106[30], 2 × 107[25] cell numbers were also used; 
in addition, 50 µg[32] of hDPSCs-Exo was indicated for the cell-free therapy strategy 
(Table 2).
DPSCs-derived from healthy pulp: (1) Loading or injecting a cell suspension of 
DPSCs. In a scaffold-based trial, Khorsand et al[25] surgically created three-walled PDs 
with ligature-induced periodontitis in 10 mongrel dogs. The PDs were produced 
bilaterally at the bone adjacent to the mesial surface of the mandibular first premolar 
teeth. They investigated the regenerative capacity of autologous dogs' DPSCs on 
periodontal tissues, with/without Bio-Oss granules. Four weeks after making the 
periodontitis model, Bio-Oss was engrafted on one side and considered as a control, 
while on the other side, a combination of 2 × 107 autologous DPSCs of passage 3 with 
Bio-Oss was engrafted and served as the test group. Evaluation was dependent on 
histologic and histomorphometric analyses, 8 wk after surgery, in terms of cementum, 
periodontal ligament, and bone formation. The authors concluded that a biocomplex 
consisting of Bio-Oss scaffold and DPSCs would be advantageous in regeneration of 
periodontal tissues. Moreover, Lin et al[30] investigated the regenerative and 
therapeutic effects of a daily dose, intragastrically administered 25 mg/kg of 2,3,5,4′-
tetrahydroxystilbene-2-O-β-d-glucoside (THSG)-triggered hDPSCs in the healing of 
experimental PDs adjacent to the roots of the second molars in male Sprague-Dawley 
rats. THSG is a water soluble and biologically active component of the Chinese herbal 
medicine Polygonum multiflorum. The defects of the negative control were treated with 
Matrigel, while the defects of the positive control received 2 × 106 hDPSCs/ Matrigel 
(vol/vol = 3:1). It was found that THSG revolutionized hDPSCs significantly and 
shortened the regenerative period of PDs by enhancing new bone formation and 
increasing expression levels of osteopontin, vascular endothelial growth factor, and 
proliferating cell nuclear antigen than those in other groups.
In a scaffold-free trial, Ma et al[26] evaluated the injection of DPSCs or bone marrow 
stem cells (BMSCs) for in vivo periodontal regeneration. The investigators created 12 
PDs of 3 mm depth, 7 mm length, and 5 mm width in miniature pigs' interradicular 
bone of the first molars. The defects were divided into three groups, namely DPSCs, 
BMSCs and control group, each with four defects. The BMSCs and DPSCs groups were 
separately injected with approximately 1 × 107 human cells in 0.6 mL of 0.9% NaCl, 
while the defects of the control group were injected with 0.9% NaCl as the cell 
injection group. Lymphocyte infiltration and impaired sulcular epithelia were evident 
in the control group but not in the DPSCs and BMSCs groups. Notably, the 
periodontal bone regeneration capacity was significantly greater for the DPSCs 
injection group compared to the BMSCs group.
(2) Cell sheet transplantation technique of DPSCs. In a scaffold-based trial, Meng 
et al[31] created a sandwich structure of hDPSCs sheet/hTDM/Matrigel to be 
subcutaneously transplanted in nude mice for 3 mo. The main objective was to 
investigate the regeneration potential of hDPSCs, and the characteristics of the above 
materials for the tooth root regeneration (bioroot). The hDPSCs sheet was obtained by 
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Table 2 Preclinical and clinical studies obtained from the PubMed, Scopus and Google Scholar databases related to periodontal tissue 
regeneration using dental pulp stem cells
Ref. Strategy Model Defect/site of cell implantation
Cell 





3-walled PDs with ligature 
induced periodontitis
2 × 107 Autologous dogs' DPSCs Loaded on the top surface of 
the scaffold




Bone defect of 5 mm 
width, 7 mm length, and 3 
mm depth
1 × 107 hDPSCs Cell injection




Bone defects of 5 mm 
width, 7 mm length, and 3 
mm depth
1 × 107 hDPSCs transfected with 
adenovirus-mediated 
transfer of HGF gene
Cell sheet transplantation or 
cell injection




Bone defect of 5 mm 
width, 7 mm length, and 3 
mm depth
1 × 107 hDPSCs Cell sheet transplantation or 
cell injection
Li et al[29], 2019 Scaffold-based Miniature 
pig
Periodontal defect of 5 
mm × 6 mm × 5 mm
1 × 107 Autologous pig DPSCs-
IPs
loaded onto the scaffold





adjacent to the root of the 
second molars
2 × 106 hDPSCs Cell injection




Nude mice Subcutaneously (bioroot 
regeneration)
5 × 105 hDPSCs Cell sheet





Mouse Periodontitis created using 
5-0 silk ligature
50 μg hDPSCs-Exo Incorporated onto the scaffold 
and combination injected 
locally
Li et al[33], 2016 Scaffold-based Human Periodontal intrabony 
defects




Scaffold-based Human Chronic periodontitis with 
deep intrabony defect 
50 μm 
micrograft
Micrografts rich in 
autologous hDPSCs
Seeded onto the scaffold
Aimetti 
et al[35], 2018




Micrografts rich in 
autologous hDPSCs




Scaffold-based Human PDs, without uncontrolled 
systemic chronic diseases
5 × 106 hDPSCs Dripped suspended in 200 mL 
of PBS and then collagen 
membrane was placed
DPSCs: Dental pulp stem cells; hDPSCs: Human dental pulp stem cells; HGF: Hepatocyte growth factor; IPs: Inflammatory dental pulp tissues; PBS: 
Phosphate-buffered saline; PDs: Periodontal defects.
seeding 5 × 105 hDPSCs in a culture dish containing complete medium supplemented 
with 20.0 μg/mL vitamin C. The hTDM was fabricated from healthy extracted teeth 
and a disk with 5 mm thickness was prepared to be successively decalcified and 
sterilized. The hTDM/hDPSCs complex was prepared by seeding hDPSCs on hTDM 
and cultured in vitro for 2 d, and the Matrigel/hDPSCs suspension was injected into 
the complex’s pulp cavity. It was concluded that hDPSCs could be used as seed cells 
for the whole tooth root regeneration, and the sandwich structure constituted by 
hDPSCs sheet, hTDM/hDPSCs and Matrigel/hDPSCs could be utilized for tooth root 
regeneration.
In a scaffold-free trial, Cao et al[27] created 40 PDs of 3 mm depth, 7 mm length, and 
5 mm width in miniature pigs, in the mesial region of the mandibular and maxillary 
first molars. Under good manufacturing practice, hDPSCs were transfected with 
adenovirus-mediated gene transfer of HGF to evaluate their potential roles for 
periodontal tissues regeneration. They found that injecting HGF-hDPSCs could 
significantly improve soft tissue healing and periodontal bone regeneration. In 
comparison to the injection of dissociated cells, HGF-hDPSCs and hDPSCs sheets 
showed superior periodontal tissue regeneration. The authors attributed their findings 
to an increase in blood vessel regeneration and a marked decrease of hDPSCs 
apoptosis caused by adenovirus-mediated gene transfer of HGF. They concluded that 
sheets are more suitable for the surgically-managed periodontitis treatments, as they 
required surgical placement. Moreover, Hu et al[28] created 24 PDs of 3 mm depth, 7 
mm length and 5 mm width in the mesial region of the mandibular and maxillary first 
molars of miniature pigs. The hDPSCs were applied using techniques of cell sheet 
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Figure 2 Periodontal bone defect. A and B: Photographs showing the periodontal defect of vertical height and horizontal width and depth of a dog’s 
interradicular bone of the first molar. Courtesy provided by the staff members of Oral Biology, Faculty of Dentistry, Mansoura University, Mansoura, Egypt.
transplantation or cell injection. The complete form of a morphologically cell sheet was 
produced by inducing hDPSCs with 20.0 μg/mL vitamin C. The cells of the cell sheet 
contacted with each other tightly and contained five or six layers. Both cell sheet 
transplantation and hDPSCs injection significantly regenerated soft tissues and 
periodontal bone. Compared with hDPSCs injection, the hDPSCs sheet had more bone 
regenerative capacity.
Finally, (3) secretome-derived from DPSCs. In a scaffold-based trial, Shen et al[32] 
created a periodontitis mouse model using 5-0 silk ligature tied around the maxillary 
left second molar to evaluate the effect of chitosan (CS) hydrogel incorporated with 
hDPSCs-derived Exo. For Exo treatment, an equal volume of phosphate-buffered 
saline /CS, hDPSCs-Exo (50 μg), and hDPSCs-Exo/CS was injected locally after 
ligature removal. It was found that treatment with hDPSCs-Exo/CS alleviated 
periodontitis via macrophage-dependent mechanism through miR-1246. hDPSCs-Exo 
facilitated the way for the macrophages to be converted from a pro-inflammatory 
phenotype to an anti-inflammatory phenotype, and suppressed periodontal 
inflammation and modulated the immune response.
DPSCs-derived from inflamed pulp: In a scaffold-based trial, Li et al[29] cultured an 
autologous miniature pig DPSCs derived from inflammatory dental pulp tissues (IPs). 
The cells were characterized and loaded onto β-tricalcium phosphate (β-TCP) 
biomaterial. The compounds were then engrafted into artificially-created PDs of 5 mm 
× 6 mm × 5 mm in the buccal region of root furcations of the third premolars and first 
molars. Compared to the β-TCP and control groups, DPSCs-IPs expressed moderate to 
high levels of CD146 and STRO-1 as well as low levels of CD45 and CD34. The cells 
have chondrogenic, adipogenic, and osteogenic differentiation abilities and when they 
were engrafted onto β-TCP, they regenerated bone of the PDs through 3 mo post-
surgical reconstruction.
Clinical studies
Autologous hDPSCs-IPs[33], micrografts rich in autologous hDPSCs[34,35] or 
autologous hDPSCs derived from healthy pulps[36] were the source for a randomized 
clinical trial (commonly referred to as RCT)[34], a 1-year follow-up case series[35], a 
quasi-experimental study[35] and a pilot study[33]. The strategy of using DPSCs was 
dependent on scaffold-based only[33-35] as they loaded onto the scaffold[33-35] or 
dripped suspended in 200 mL of phosphate-buffered saline and then the scaffold 
membrane was placed[36]. Patients diagnosed with combined periodontal-endodontic 
lesions with pocket depth from 5 mm to 6 mm[33], patients with chronic periodontitis 
combined with deep intrabony defects[34,35], and patients with controlled chronic 
diseases and without horizontal PDs or osteoporosis[36] were the models used for cell 
implantation. Either 1 × 105[33] or 5 × 105[36] and 50 µm micrografts rich in autologous 
hDPSCs were the cell number/source that was indicated for the scaffold-based 
strategy (Table 2).
DPSCs-derived from healthy pulp: In a scaffold-based trial, Ferrarotti et al[34] 
performed a RCT for 29 consecutively enrolled patients with chronic periodontitis 
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presenting one deep intrabony defect and requiring extraction of one vital tooth. They 
randomly allocated the defects to two groups, test or control ones. They prepared 
micrografts rich in autologous DPSCs from the DP of the extracted teeth through 
mechanical dissociation. With the use of minimally invasive surgical technique, the 
test sites were packed with micrografts seeded onto collagen sponge, whereas the 
control sites were filled with collagen sponge alone. Their findings exhibited a 
significantly more probing depth reduction, clinical attachment level gain and bone 
defect fill in the test sites compared to control ones. It was found that application of 
DPSCs significantly improved clinical parameters of periodontal regeneration at 1 year 
after treatment. In addition, Aimetti et al[35] performed a case series with 1-year 
follow-up for 11 patients with chronic periodontitis superimposed by 11 isolated 
intrabony defects to explore the potential clinical benefits of the application of DPSCs 
in the regenerative treatment of deep intrabony defects. Extraction was performed for 
malposed/impacted teeth to be used as autologous source for DPSCs. The defects 
were accessed with a minimally invasive flap and filled with DPSCs loaded on a 
collagen sponge. After 1 year posttreatment, a clinical attachment level gain associated 
with probing depth reduction and a notable stability of the gingival margin was 
detected using clinical outcomes supported by the radiographic analysis. In 63.6% of 
the experimental sites, complete pocket closure was achieved. Moreover, a quasi-
experimental study was conducted by Hernández-Monjaraz et al[36] for 22 adults with 
PDs, without uncontrolled systemic chronic diseases. Every participant underwent 
clinical and radiological evaluations and saliva samples were taken to determine the 
total concentration of interleukins (ILs), antioxidants, lipoperoxides, and superoxide 
dismutase (SOD). All subjects underwent curettage and periodontal surgery and then 
two groups were allocated randomly, namely experimental and control groups. The 
defects of the control group had a collagen scaffold, while the experimental one had a 
collagen scaffold treated with DPSCs. The experimental group showed an increase in 
the bone mineral density of the alveolar bone with a borderline statistical significance. 
Regarding inflammation and oxidative stress markers, IL1β levels had a level 
decrease, while salivary SOD level was significantly higher in the experimental group. 
Their findings suggest that treatment based on DPSCs has both an effect on bone 
regeneration linked to an increased SOD and decreased levels of IL1β in subjects with 
PDs.
DPSCs-derived from inflammatory pulp: In a scaffold-based trial, Li et al[33] 
harvested DPSCs-IPs from 2 patients with periodontal intrabony defects and then they 
were loaded onto the scaffold material β-TCP and engrafted into the PD area in the 
root furcation. At 9 mo after surgical reconstruction, DPSCs-IPs were able to engraft 
and had an effect of regeneration of new bones to repair PDs. The success rate of 
primary cell culture and growth status was marginally inhibited; however, DPSCs-IPs 
expressed comparable levels of stem cell markers as well as retaining their ability to 
multi-differentiate.
REGENERATION OF SGS USING DPSCS 
The parotid, submandibular (SMG) and sublingual glands are the three pairs of major 
SGs. The anatomical architecture of all three glands is virtually identical, with different 
ratios of serous and mucous cells: an arborized ductal system that opens into the oral 
cavity with secretory end pieces, or the acini-producing saliva. The acinar cells are 
surrounded by an extracellular matrix, myoepithelial cells, myofibroblasts, immune 
cells, endothelial cells, stromal cells and nerve fibers. The ducts transport and modify 
the saliva before it is excreted into the oral cavity through the excretory duct[37]. The 
aim of regenerative medicine is to replace/regenerate the SG epithelium and restore 
its secretory function in patients suffering from permanent loss of major SG function, 
after radiotherapy of head and neck cancer, which is the sixth most common cancer in 
the world and affects tens of thousands of new patients every year, causing 
hyposalivation/xerostomia with subsequent difficulties in mastication, swallowing, 
taste, speech, high patient discomfort and a reduced quality of life. Palliative therapies 
show a limited effectiveness in relieving the symptoms, such as mechanical 
stimulation of SG activity using chewing gum, or pharmacological agents such as 
pilocarpine, as well as saliva substitutes[38]. Adult stem cell transplantation strategies 
have recently shown to enhance clinical outcomes in radiotherapy-induced xerostomia 
in rodents. Mesenchymal stem cells from adipose tissue are the most promising[39], 
while those from the labial mucosa, bone marrow or DP have an attractive therapeutic 
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value following successful findings in ex vivo and in vivo mouse models of SG injury. 
DPSCs are supposed to be a good source for SG regeneration by being a component of 
epithelial acinar cells itself or by being a SG mesenchymal component to encourage 
and support the regeneration process of the SGs. In SG bioengineering, the principal 
role of DPSCs is to regenerate the salivary stroma or mesenchymal-derived 
compartment, and these cells are one of the best choices for that purpose because the 
tooth mesenchyme and the SG mesenchyme share a common neural crest embryonic 
origin[40]. A radiation model was developed to reproduce the hyposalivation induced 
by head and neck cancer therapy. The ductal ligation model aimed to mimic the 
obstructive sialadenitis and sialithiasis-induced sialopathy and tissue punch 
considered as a model of mechanical injury (Figure 3). Systemic disease/medication 
was devised to correspond to Sjogren’s syndrome[41].
Preclinical studies
Autologous[42,43], xenogeneic[44] DPSCs or their Exo[45] have been isolated from 
healthy[42-45] DP. The strategy of using DPSCs was dependent on scaffold-based[42], 
scaffold-free[43,44] and cell-free[45] therapies. Application of DPSCs was in the form 
of cell injection[42-44]. Mice were the most selected model for studying the 
regenerative effect of DPSCs for SG regeneration in the pre-clinical trials. Other 
animals such as rat[43] were also selected for the same purpose. Irradiation-induced 
SG hypofunction[43] and duct ligation-induced atrophy[45] or salivary hypofunction 
induced by diabetes[44] were the presented study models. The cell number of 1 × 106 
was the most commonly used[42,43] but 5 × 105[44] cell number was also used, and 0.4 
mL[45] of DPSCs-CM was indicated for the cell-free therapy strategy (Table 3).
DPSCs-derived from healthy pulp: (1) Subcutaneous and intraglandular injection of 
cell suspension of DPSCs. In a scaffold-based trial, Janebodin et al[42] created an in-
vivo model to study the differentiation effect of DPSCs to support SG tissue formation. 
They subcutaneously transplanted either 1 × 106 hSG cells alone or 1 × 106 hSG cells 
combined with 1 × 106 murine DPSCs. These cells were transplanted with hyaluronic 
acid (HA) hydrogel scaffold into 2-mo-old male Rag1 null mice to avoid immune 
rejection against hSG. The cells were injected ventrally onto SMG without penetrating 
the gland in the form of 100 μL of cell suspension. After 2 wk of transplantation, HA 
plugs were dissected without involving mouse recipients’ SG tissues, to be 
investigated with hematoxylin and eosin, periodic acid Schiff and immunofluore-
scence staining. Histological evaluation revealed that combination between hSG + 
DPSCs contributed to the generation of salisphere-like structures. These salispheres 
expressed markers of terminally differentiated acinar cells and after subcutaneous 
transplantation in mice, developing a well-irrigated SG-like tissue. These findings 
provide evidence of the potential use of DPSCs as ecto-mesenchyme for induction and 
support of SG development.
In a scaffold-free trial, Yamamura et al[43] established a mouse model in which 
DPSCs were used as a cell source for treatment of irradiation-induced SG 
hypofunction. DPSCs were isolated from female C57BL/6J green fluorescent protein-
expressing mice and were differentiated into dental pulp endothelial cells (DPECs). 
Both SMG of the irradiated mice were injected with 1 × 106 DPECs/gland. Eight weeks 
after irradiation, the effect of DPECs on saliva secretion was evaluated by measuring 
amounts of saliva secretion. It was found that transplantation of DPSCs are highly 
effective in maintaining saliva production after irradiation through direct 
differentiation of into salivary epithelial cells. This study established a mouse model in 
which DPSCs could be used as a cell source for the treatment of SG hypofunction. 
Moreover, Narmada et al[44] injected intraglandular tissues of the SMG in diabetic 
Wistar rat models once with 5 × 105 cells of hDPSCs/250 g in 0.2 mL phosphate-
buffered saline solution. The control diabetic rats were injected only with 0.2 mL of 
phosphate-buffered saline intraglandular. Half of the rats was sacrificed after 7 d, 
while the remaining rats were sacrificed after 14 d for immunohistochemical 
evaluation. It was found that transplantation of DPSCs was able to regenerate SMG 
defects in diabetic Wistar rats by decreasing acinar cell vacuolization.
(2) Secretome from DPSCs. Takeuchi et al[45] collected cell culture supernatant from 
subconfluently DPSCs culture (DPSC-CM). DP tissues were collected from healthy 
teeth extracted from individuals. The SMG duct was ligated approximately 2 mm 
superior to the main body of the gland with a sugita titanium aneurysm clip. The 
experimental groups were divided into a DMEM group (in which 0.4 mL DMEM was 
administered via the right jugular vein biweekly) and a CM group (in which 0.4 mL 
DPSC-CM was administered using a similar method); the control group was 
composed of mice that underwent only the release of ligation. Injection of DPSCs-CM 
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Table 3 Preclinical studies obtained from the PubMed, Scopus and Google Scholar databases related to salivary gland regeneration 
using dental pulp stem cells









Rag1 null mice Injected ventrally onto SMG 
without penetrating the 
gland
1 × 106 Murine 
DPSCs 








Irradiated SMG 2 × 106 Murine 
DPSCs
5 μL of single cell suspension was injected 






Wistar rats SMG of diabetic rat model 5 × 105 hDPSCs Intraglandular cell injection.
Takeuchi 
et al[45], 2020
Cell-free ICR mice SMG duct ligation 0.4 mL hDPSCs DPSCs-CM was administered via the right 
jugular vein biweekly under general 
anaesthesia. 
DPSCs: Dental pulp stem cells; hDPSCs: Human dental pulp stem cells; SMG: Submandibular.
Figure 3 Punch biopsy of submandibular gland. A: Photographs showing a tissue punch of submandibular (SMG) as a model of mechanical injury through 
disinfecting the skin of operation site by betadine; B: Exposing the right SMG; C: Applying the tissue punch on the center of right SMG; D: The arrow points to a 
rectangular cut area of 5 mm × 8 mm × 1.5 mm dimensions. Courtesy provided by the staff members of Oral Biology, Faculty of Dentistry, Mansoura University, 
Mansoura, Egypt.
to mice after releasing the SMG main duct ligation significantly elevated the 
expression levels of precursor cell marker CK5 and acinar cell marker AQP5 after the 
release. Growth factors contained in DPSCs-CM were considered to be responsible for 
the effects. This study suggested that DPSCs-CM administration to mice after releasing 
the SMG main duct ligation may promote acinar cell regeneration of atrophied SGs.
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REGENERATION OF BONE DEFECTS USING DPSCS
Bone fractures appear to occur more often in old age because of bone weakening due 
to a reduction in calcium content in extracellular matrix and slowing of bone 
remodeling processes. Current methods of treatment are unable to fully reconstruct 
bone defects that are caused by fractures, tumors and congenital abnormalities. At 
present, autogenous or allogeneic bones and artificial materials are used for bone 
augmentation. However, there are various problems with these grafts, such as the 
possibility of infection or absorption as well as ethical issues. Alternatively, the 
periosteum and the bone marrow are considered rich in bone progenitors, so that the 
bone, since early 1990s, has been one of the approachable goals of clinical TE[46]. In 
addition, osteogenic differentiation of DPSCs is easily induced in vitro by adding 
ascorbic acid, dexamethasone, and β-glycerophosphate to the culture medium, along 
with fetal bovine serum, making these cells a promising tool for bone regenera-
tion[47]. Bone defect repair is characterized by three overlapping processes, namely 
the formation of blood clot, bone formation, and bone remodeling. Osteoprogenitor 
cells migrate to the wound site during the second phase, proliferate and differentiate 
into osteoblasts that segregate and induce mineralization. DPSCs are a vital source of 
osteoprogenitor cells which play a fundamental role in the bone tissue plasticity-
related mechanisms[48-50].
Preclinical studies
Autologous[51] or xenogeneic[49,50,52] DPSCs have been isolated from healthy[50-52] 
DP. The strategy of using DPSCs was dependent on scaffold-based[52], scaffold-
free[50,51] therapies. Application of DPSCs was in the form of cell sheet 
transplantation[51], loaded onto the scaffold[52] or, incorporated onto the PRP and the 
combination was injected locally[50]. Animals such as rabbit[52], mice[51] and 
dogs[50] were selected to study bone regeneration preclinically. Mandibular[50] 
(Figure 4), calvarial[51] and craniofacial[52] bone defects were presented. The cell 
number of 1 × 107 was the most commonly implicated[50] but 2 × 106[52] was also used 
(Table 4).
DPSCs-derived from healthy pulp: (1) Loading or injecting a cell suspension of 
DPSCs. In a scaffold-based trial, Mohammed et al[52] loaded 2 × 106 hDPSCs on gel 
foam scaffold to be fitted in induced temporomandibular joint defect area of 2.5 mm × 
2.5 mm in diameter and in depth for the rabbit’s mandible. The histological 
investigation was performed for qualitative evaluation of bone healing and it was 
found that newly formed bone with thick trabecular pattern and less osteoid tissue 
have been observed in the experimental rabbits transplanted with osteogenic-
differentiated hDPSCs. The authors suggested the ability of transplanted osteogenic 
differentiated hDPSCs to produce new osteoid tissue that helps in repairing an 
induced rabbit mandibular defect in a time and differentiation phase-dependent 
manner. In an attempt to confirm that bone regeneration was indeed the function of 
hDPSCs, Chamieh et al[53] tested the efficacy of DPSCs seeded on a collagen scaffold 
for craniofacial bone regeneration. Plastically compressed collagen gels were loaded 
with DPSCs (2 × 106 cells/mL) which were isolated from molar Wistar rats. A 5-mm 
diameter calvarial critical-sized defect was created on each side of the parietal bone 
using a dental bur attached to a slow-speed hand piece operating at 1500 rpm, under 
irrigation with sterile saline solution; empty defects were created as a negative control 
for the critical-sized defects. It was found that collagen gel scaffolds seeded with 
DPSCs improved bone healing and the remodeling process under micro-X-ray 
computed tomography as well as histological examination.
Liu et al[50] utilized nano-hydroxyapatite/collagen/PLLA as a scaffold for 
autologous DPSCs seeding to reconstruct critical-size alveolar bone defects in New 
Zealand rabbit. A 10 mm incision was made and the tissue overlying the diaphysis of 
the left alveolar bone of incisors of rabbits was dissected. A segmental defect of 10 mm 
× 4 mm × 3 mm was prepared in the alveolar bone. Cell number of 1 × 106 DPSCs was 
implanted onto the scaffold and transplanted into the alveolar bone defect. The 
animals were sacrificed 12 wk after operation for histological observation and 
histomorphometric analysis. It was found that reconstruction of alveolar bone defects 
using DPSCs seeded on nano-hydroxyapatite/collagen/PLLA had earlier 
mineralization and more bone formation than achieved with the scaffold alone or even 
the autologous bone graft.
In a scaffold-free trial, Yamada et al[49] tried to test the osseointegration around the 
implant during the healing period using DPSCs. Human DPSCs were obtained from 
extracted permanent teeth. Adult hybrid dogs with a mean age of 2 years were 
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Table 4 Preclinical and clinical studies obtained from the PubMed, Scopus and Google Scholar databases related to bone regeneration 
using dental pulp stem cells





Dogs Mandibular bone defects were 
prepared using a trephine bur with 
a diameter of 10 mm
1 × 107 hDPSCs Cavities filled with DPSCs/PRP




Rabbit A segmental critical size defect (10 
mm × 4 mm × 3 mm) was prepared 
in the alveolar bone
1 × 106 Autologous 
DPSCs
DPSCs were seeded onto nano- 
hydroxyapatite/collagen/PLLA and implanted 
in-vivo











Rabbit Craniofacial bone defect in the left 
side of TMJ















Human Defect without walls, of at least 1.5 
cm in height
1 × 107 Autologous 
DPSCs
Cells endorsed with a syringe onto collagen 
sponge scaffold
DPSCs: Dental pulp stem cells; hDPSCs: Human dental pulp stem cells; NA: Not available; PRP: Platelet-rich plasma.
Figure 4 Mandibular bone defect. A: Photograph showing a 10-mm diameter, full-thickness mandibular defect with the removal of the mandibular first premolar 
and both cortical plates; B: Cone-beam computed tomography systems reconstruction of the critical-size bone defect; C: The 10-mm trephine bur with autogenous 
tibial bone graft; D: Gelfoam placed on the defect. Courtesy provided by the staff members of Oral Biology, Faculty of Dentistry, Mansoura University, Mansoura, 
Egypt.
operated on under general anesthesia. In the mandible region, the first molar and the 
second and third premolars were extracted, and the healing period was 2 mo. Bone 
defects were prepared on both sides of the mandible using a trephine bur with a 
diameter of 10 mm. The defects were implanted with DPSCs or BMSCs (1 × 107 
cell/mL) plus PRP while the defect-only represented the control group. After 8 wk, an 
HA-coated osseointegrated dental implant was inserted into the bone regeneration 
areas and was assessed histologically. The dogs were sacrificed 16 wk after insertion of 
the dental implant. A histological analysis was performed to obtain a general 
description of the tissue surrounding the implants. Cavities filled with DPSCs/PRP or 
BMSCs/PRP were found to show new bone formation at 8 wk with a tubular pattern 
along with abundant vascularization. This pattern reflected normal bone 
macrostructure with well-differentiated marrow cavity and cortices, while the cavities 
in the control group were invaded by vascular and fibrous tissues. Bone-implant 
contact revealed significant increase in the group treated with DPSCs/PRP or 
BMSCs/PRP in comparison to controls.
(2) Cell sheet transplantation technique of DPSCs. In a scaffold-free trial, Fujii 
et al[51] evaluated bone regeneration by hDPSCs using a helioxanthin derivative and 
cell-sheet technology. DPSCs were cultured on temperature-responsive dishes after 
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treatment with osteogenic medium for 14 d then the sheets were folded to fit the 3.5-
mm calvarial defects of mice. The skin and subcutaneous layer were then closed by 6-0 
nylon sutures. Eight weeks after surgery, calvarial defect sites were harvested from 
euthanized mice. Micro-CT images showed that the DPSC sheets were able to induce 
bone formation without requiring scaffold or growth factors. Cell sheets are flexible 
and simple to transplant, so this technology may replace conventional bone graft 
methods in the future.
Clinical studies
Autologous hDPSCs were the source for a RCT[42] with 3 mo follow-up case series. 
The strategy of using DPSCs was dependent on scaffold-based only. Patients 
diagnosed with bilateral bone resorption following impaction surgery of impacted 
third molars are presented (Table 4).
DPSCs for cell and scaffold-based strategy: D’Aquino et al[54] utilized DPSCs and a 
collagen sponge scaffold for oro-maxillo-facial bone tissue repair in patients requiring 
extraction of their third molars. The patients suffered from bilateral alveolar bone 
reabsorption distal to the second molar following impaction of the third molar on the 
cortical alveolar lamina, producing a defect without walls, of 1.5 cm in height. 
Extraction of the third molar in this clinical condition does not permit spontaneous 
bone repair and ultimately leads to loss of the adjacent second molar as well. For DPC 
isolation and expansion, maxillary third molars were extracted. The cells were then 
seeded onto a collagen sponge scaffold and the biocomplex obtained was used to fill in 
the injury site left by extraction of the mandibular third molars. At 3 mo after 
autologous DPSCs grafting, the patients alveolar bone had optimal vertical repair and 
complete restoration of periodontal tissue back to the second molars, as assessed by 
clinical probing and X-rays.
CONCLUSION
DPSCs have emerged as a promising tool with a great potential for dental and oral 
tissue regeneration or engineering. However, many issues and challenges still need to 
be addressed before these cells can be employed in clinical practice. The full control of 
differentiation of DPSCs to specific fates is still an important issue, and although 
DPSCs derivation to certain connective tissue-lineage cells appears to be relatively 
simple, their differentiation into nerve-tissue lineages still poses important 
unanswered questions. Moreover, the development of the cell recombination 
technology required to create next-generation bioengineered replacement organs will 
necessitate extensive research for the coming years. In this case, DPSCs may be an 
ideal choice to be used in experimental models of tissue-engineered reconstruction of 
organs of the oral cavity, and the paradigmatic cases of the tooth and the SG may 
constitute the leading edge of a massive research effort on next generation organ 
replacement therapies[2].
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